This is the text extract for Tender Results, browse documents here.

---

FAX

Tender Results

To: From: Date: All Suppliers and Wholesalers PHARMAC 31 March 2009 No of Pages (including this one): 3

Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 15 December 2006 and the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 13th April 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2006/07 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing for tender winning brand at the tender subsidy will occur on 1 May 2009, reference pricing of non-tender winning brand will occur on 1 July 2009 and Sole Subsidised Supply commences on 1 October 2009.

The decisions were as follows:

Chemical Name Terazosin hydrochloride* Terazosin hydrochloride*

Presentation; Pack size and type Tab 2 mg; 500 tablets, bottle Tab 5 mg; 500 tablets, bottle

Current Subsidy $1.48 (28 tablets) $1.91 (28 tablets)

New tender subsidy $23.30 (500 tablets) $29.00 (500 tablets)

Sole supply brand (Supplier) Apo-Terazosin (Apotex) Apo-Terazosin (Apotex)

Brands affected by reference pricing and delisting Hytrin (Abbott) Hytrin (Abbott)

*This product will become fully subsidised. Please note that PHARMAC is also currently consulting on the listing of Apo-Terazosin 1 mg tablets. Please refer to our website for a copy of the consultation - http://www.pharmac.govt.nz/patients/consultation

A269603 - qA12214

---

2008/09 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to listed pharmaceuticals where no other brand is listed – subsidy changes on 1 May 2009 and Sole Subsidised Supply commences on 1 August 2009.

The decisions were as follows:

Chemical Name Acarbose Acarbose Ciclopiroxolamine * Entacapone Erythromycin ethyl succinate Furosemide Hydroxychloroquine sulphate Methadone hydrochloride Methadone hydrochloride Methadone hydrochloride

Presentation; Pack size and type Tab 50 mg; 90 tablets, blister Tab 100 mg; 90 tablets, blister Nail soln 8%; 3.5 ml OP, bottle Tab 200 mg; 100 tablets, bottle Tab 400 mg; 100 tablets, bottle Tab 40 mg; 1,000 tablets, bottle Tab 200 mg; 100 tablets, bottle Oral liq 2 mg per ml; 200 ml, bottle Oral liq 5 mg per ml; 200 ml, bottle Oral liq 10 mg per ml; 200 ml, bottle

Current Subsidy $22.00 $31.00 $37.81 $129.00 $18.95 $11.50 $31.09 $6.55 $6.52 $9.50

New tender subsidy $16.50 $26.70 $19.85 $116.00 $16.95 $10.75 $22.50 $5.95 $5.55 $8.95

Sole supply brand (Supplier) Glucobay (Bayer) Glucobay (Bayer) Batrafen (Sanofi-Aventis) Comtan (Novartis) E-mycin (Mylan) Diurin 40 (Mylan) Plaquenil (Sanofi-Aventis) Biodone (Biomed) Biodone Forte (Biomed) Biodone Extra Forte (Biomed)

* This product will become fully subsidised.

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where only the current brand is listed – price changes for hospital tender winning brands of the pharmaceuticals will occur in Section H of the Pharmaceutical Schedule on 1 May 2009; DV Limits and DV Pharmaceuticals will apply from 1 July 2009.

The decisions were as follows:

Chemical Name Erythromycin ethyl succinate Furosemide Hydroxychloroquine sulphate Methadone hydrochloride Methadone hydrochloride Methadone hydrochloride

Presentation; Pack size and type Tab 400 mg; 100 tablets, bottle Tab 40 mg; 1,000 tablets, bottle Tab 200 mg; 100 tablets, bottle Oral liq 2 mg per ml; 200 ml, bottle Oral liq 5 mg per ml; 200 ml, bottle Oral liq 10 mg per ml; 200 ml, bottle

Hospital Supply Status Brand (Supplier) E-mycin (Mylan) Diurin 40 (Mylan) Plaquenil (SanofiAventis) Biodone (Biomed) Biodone Forte (Biomed) Biodone Extra Forte (Biomed)

Pack Price $16.95 $10.75 $22.50 $5.95 $5.55 $8.95

DV Limit 1% 1% 1% 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) Apo-Frusemide (Apotex) Frusehexal (Novartis) Frusid (Douglas) (B) (B) (B) (B)

A269603 - qA12214

2

---

3. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 May 2009 and DV Limits and DV Pharmaceuticals will apply from 1 July 2009.

The decisions were as follows:

Chemical Name Acarbose Acarbose Entacapone

Presentation; Pack size and type Tab 50 mg; 90 tablets, blister Tab 100 mg; 90 tablets, blister Tab 200 mg; 100 tablets, bottle

Hospital Supply Status Brand (Supplier) Glucobay (Bayer) Glucobay (Bayer) Comtan (Novartis)

Pack Price $16.50 $26.70 $116.00

DV Limit 1% 1% 1%

DV Pharmaceuticals Brand Name (Supplier) (B) (B) (B)

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.

The decisions were as follows:

Chemical Name Amsacrine Folic Acid Folic Acid Folic Acid Ketamine Hydrochloride Ketamine Hydrochloride Ketamine Hydrochloride Zuclopenthixol Hydrochloride Zuclopenthixol Hydrochloride Zuclopenthixol Hydrochloride Zuclopenthixol Hydrochloride

Line Item Inj 50 mg per 1 ml Tab 0.4 mg Tab 0.8 mg Tab 5 mg Inj 10 mg per ml Inj 50 mg per ml Inj 100 mg per ml Tab 2 mg Tab 10 mg Tab 25 mg Tab 40 mg

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A269603 - qA12214

3